BIOCRYST PHARMACEUTICALS INC
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is a biotechnology company focused on discovering and developing novel small-molecule and protein therapeutics for rare diseases. The company operates through its primary business of drug development and commercialization, with a particular emphasis on complement-mediated… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What BIOCRYST PHARMACEUTICALS INC does
In the company’s own words
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is a biotechnology company focused on discovering and developing novel small-molecule and protein therapeutics for rare diseases. The company operates through its primary business of drug development and commercialization, with a particular emphasis on complement-mediated rare diseases and other therapeutic areas where unmet medical needs exist.
The company's pipeline includes both clinical-stage and commercial-stage programs targeting conditions such as paroxysmal nocturnal hemoglobinuria, C3 glomerulopathy, post-transplant complications, and other rare genetic and acquired disorders. BioCryst leverages its expertise in structure-based drug design and protein engineering to develop treatments that address the underlying causes of rare diseases rather than merely managing symptoms.
BioCryst's business model centers on the discovery, development, and commercialization of innovative therapeutics, with revenue generation from product sales, licensing agreements, and potential milestone payments from partnerships. The company maintains research and development facilities and operates commercial operations to support the launch and marketing of approved products. The organization maintains a global presence with operations across multiple jurisdictions to support its clinical development programs and commercial activities.
The company's competitive advantages include its proprietary drug discovery and development platform, expertise in complement biology and other disease mechanisms, and a focused pipeline strategy targeting areas with significant unmet medical needs in rare disease populations. BioCryst's approach emphasizes precision medicine and mechanism-based therapeutics, positioning it within the specialized biotechnology sector serving patients with rare genetic and acquired disorders.
The company's financial structure reflects typical biotechnology industry characteristics, with significant research and development investments supporting its pipeline advancement and commercialization efforts. BioCryst maintains strategic partnerships and collaborations to enhance its development capabilities and expand its market reach. The organization is committed to advancing its pipeline programs through clinical development stages toward regulatory approval and commercialization.
BioCryst's website is located at www.biocryst.com.
Company details
- Sector
- Healthcare
- Industry
- Biological Products
- Headquarters
- DURHAM, NC
- Fiscal year end
- December
- CIK
- 882796
- SIC
- 2836
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns BIOCRYST PHARMACEUTICALS INC — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · BIOCRYST PHARMACEUTICALS INC’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do BIOCRYST PHARMACEUTICALS INC and its peers compare on margins and cash generation over ten years?”
- “Where did five years of BIOCRYST PHARMACEUTICALS INC's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in BIOCRYST PHARMACEUTICALS INC's last four quarterly filings that the numbers alone won't show?”